Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Boehringer Ingelheim
Dow
Colorcon
AstraZeneca

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Dr Reddys Labs Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for DR REDDYS LABS INC, and what generic and branded alternatives to DR REDDYS LABS INC drugs are available?

DR REDDYS LABS INC has twenty-two approved drugs.

There are two tentative approvals on DR REDDYS LABS INC drugs.

Summary for Dr Reddys Labs Inc
US Patents:0
Tradenames:20
Ingredients:20
NDAs:22

Drugs and US Patents for Dr Reddys Labs Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Inc NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE naproxen sodium; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 077381-001 Sep 27, 2006 OTC No No   Start Trial   Start Trial
Dr Reddys Labs Inc SIMVASTATIN simvastatin TABLET;ORAL 077752-001 Dec 20, 2006 AB RX No No   Start Trial   Start Trial
Dr Reddys Labs Inc NEFAZODONE HYDROCHLORIDE nefazodone hydrochloride TABLET;ORAL 076309-003 Sep 16, 2003 DISCN No No   Start Trial   Start Trial
Dr Reddys Labs Inc SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 076847-002 Aug 10, 2009 AB RX No No   Start Trial   Start Trial
Dr Reddys Labs Inc ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077565-002 Mar 2, 2012 AB RX No No   Start Trial   Start Trial
Dr Reddys Labs Inc RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 077130-001 Oct 31, 2007 AB RX No Yes   Start Trial   Start Trial
Dr Reddys Labs Inc RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 077130-004 Oct 31, 2007 AB RX No Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Colorcon
McKinsey
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.